nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Triamcinolone—psoriatic arthritis	0.358	0.417	CbGbCtD
Mitotane—SERPINA6—Prednisolone—psoriatic arthritis	0.303	0.353	CbGbCtD
Mitotane—CYP11A1—Dexamethasone—psoriatic arthritis	0.197	0.23	CbGbCtD
Mitotane—Blood triglycerides increased—Prednisone—psoriatic arthritis	0.000949	0.0067	CcSEcCtD
Mitotane—Mucosal inflammation—Methotrexate—psoriatic arthritis	0.000938	0.00663	CcSEcCtD
Mitotane—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000937	0.00662	CcSEcCtD
Mitotane—Fungal infection—Dexamethasone—psoriatic arthritis	0.000924	0.00653	CcSEcCtD
Mitotane—Fungal infection—Betamethasone—psoriatic arthritis	0.000924	0.00653	CcSEcCtD
Mitotane—Anorexia—Auranofin—psoriatic arthritis	0.000912	0.00645	CcSEcCtD
Mitotane—Dyspepsia—Auranofin—psoriatic arthritis	0.000843	0.00595	CcSEcCtD
Mitotane—Dermatitis atopic—Prednisone—psoriatic arthritis	0.00084	0.00593	CcSEcCtD
Mitotane—Decreased appetite—Auranofin—psoriatic arthritis	0.000832	0.00588	CcSEcCtD
Mitotane—Cataract—Triamcinolone—psoriatic arthritis	0.000826	0.00584	CcSEcCtD
Mitotane—Encephalopathy—Methotrexate—psoriatic arthritis	0.000809	0.00572	CcSEcCtD
Mitotane—Fungal infection—Prednisone—psoriatic arthritis	0.000805	0.00569	CcSEcCtD
Mitotane—Endocrine disorder—Prednisone—psoriatic arthritis	0.00075	0.0053	CcSEcCtD
Mitotane—Cataract—Betamethasone—psoriatic arthritis	0.00075	0.0053	CcSEcCtD
Mitotane—Cataract—Dexamethasone—psoriatic arthritis	0.00075	0.0053	CcSEcCtD
Mitotane—Injury—Prednisolone—psoriatic arthritis	0.000676	0.00477	CcSEcCtD
Mitotane—Fungal infection—Methotrexate—psoriatic arthritis	0.000673	0.00475	CcSEcCtD
Mitotane—Hypercholesterolaemia—Prednisone—psoriatic arthritis	0.000657	0.00464	CcSEcCtD
Mitotane—Diarrhoea—Auranofin—psoriatic arthritis	0.000655	0.00463	CcSEcCtD
Mitotane—Cataract—Prednisone—psoriatic arthritis	0.000653	0.00461	CcSEcCtD
Mitotane—Injury—Triamcinolone—psoriatic arthritis	0.000621	0.00439	CcSEcCtD
Mitotane—Osteoarthritis—Prednisolone—psoriatic arthritis	0.000621	0.00439	CcSEcCtD
Mitotane—Injury—Methylprednisolone—psoriatic arthritis	0.00062	0.00438	CcSEcCtD
Mitotane—Vomiting—Auranofin—psoriatic arthritis	0.000609	0.0043	CcSEcCtD
Mitotane—Amnesia—Methylprednisolone—psoriatic arthritis	0.000606	0.00428	CcSEcCtD
Mitotane—Speech disorder—Methotrexate—psoriatic arthritis	0.000604	0.00427	CcSEcCtD
Mitotane—Rash—Auranofin—psoriatic arthritis	0.000604	0.00426	CcSEcCtD
Mitotane—Dermatitis—Auranofin—psoriatic arthritis	0.000603	0.00426	CcSEcCtD
Mitotane—Proteinuria—Methotrexate—psoriatic arthritis	0.000591	0.00418	CcSEcCtD
Mitotane—Protein urine present—Methotrexate—psoriatic arthritis	0.000583	0.00412	CcSEcCtD
Mitotane—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.000571	0.00403	CcSEcCtD
Mitotane—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.00057	0.00403	CcSEcCtD
Mitotane—Nausea—Auranofin—psoriatic arthritis	0.000569	0.00402	CcSEcCtD
Mitotane—Injury—Betamethasone—psoriatic arthritis	0.000564	0.00398	CcSEcCtD
Mitotane—Injury—Dexamethasone—psoriatic arthritis	0.000564	0.00398	CcSEcCtD
Mitotane—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.000549	0.00388	CcSEcCtD
Mitotane—Dysarthria—Methotrexate—psoriatic arthritis	0.000549	0.00388	CcSEcCtD
Mitotane—Muscular weakness—Prednisolone—psoriatic arthritis	0.000548	0.00387	CcSEcCtD
Mitotane—Irritability—Methylprednisolone—psoriatic arthritis	0.000544	0.00384	CcSEcCtD
Mitotane—Lethargy—Betamethasone—psoriatic arthritis	0.000529	0.00374	CcSEcCtD
Mitotane—Lethargy—Dexamethasone—psoriatic arthritis	0.000529	0.00374	CcSEcCtD
Mitotane—Osteoarthritis—Betamethasone—psoriatic arthritis	0.000518	0.00366	CcSEcCtD
Mitotane—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.000518	0.00366	CcSEcCtD
Mitotane—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000515	0.00364	CcSEcCtD
Mitotane—Muscular weakness—Triamcinolone—psoriatic arthritis	0.000504	0.00356	CcSEcCtD
Mitotane—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.000503	0.00355	CcSEcCtD
Mitotane—Irritability—Betamethasone—psoriatic arthritis	0.000495	0.00349	CcSEcCtD
Mitotane—Irritability—Dexamethasone—psoriatic arthritis	0.000495	0.00349	CcSEcCtD
Mitotane—Injury—Prednisone—psoriatic arthritis	0.000491	0.00347	CcSEcCtD
Mitotane—Amnesia—Prednisone—psoriatic arthritis	0.00048	0.00339	CcSEcCtD
Mitotane—Neoplasm—Methotrexate—psoriatic arthritis	0.00047	0.00332	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—psoriatic arthritis	0.000465	0.00328	CcSEcCtD
Mitotane—Lethargy—Prednisone—psoriatic arthritis	0.000461	0.00325	CcSEcCtD
Mitotane—Muscular weakness—Betamethasone—psoriatic arthritis	0.000457	0.00323	CcSEcCtD
Mitotane—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000457	0.00323	CcSEcCtD
Mitotane—Osteoarthritis—Prednisone—psoriatic arthritis	0.000451	0.00319	CcSEcCtD
Mitotane—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000439	0.0031	CcSEcCtD
Mitotane—Infestation—Methylprednisolone—psoriatic arthritis	0.000439	0.0031	CcSEcCtD
Mitotane—Irritability—Prednisone—psoriatic arthritis	0.000431	0.00304	CcSEcCtD
Mitotane—Visual impairment—Prednisolone—psoriatic arthritis	0.000414	0.00292	CcSEcCtD
Mitotane—Muscular weakness—Prednisone—psoriatic arthritis	0.000398	0.00281	CcSEcCtD
Mitotane—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000387	0.00274	CcSEcCtD
Mitotane—Lethargy—Methotrexate—psoriatic arthritis	0.000385	0.00272	CcSEcCtD
Mitotane—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00038	0.00268	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000377	0.00266	CcSEcCtD
Mitotane—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000368	0.0026	CcSEcCtD
Mitotane—Neutropenia—Prednisone—psoriatic arthritis	0.000365	0.00258	CcSEcCtD
Mitotane—Irritability—Methotrexate—psoriatic arthritis	0.00036	0.00254	CcSEcCtD
Mitotane—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000358	0.00253	CcSEcCtD
Mitotane—Ataxia—Methotrexate—psoriatic arthritis	0.000355	0.00251	CcSEcCtD
Mitotane—Vision blurred—Prednisolone—psoriatic arthritis	0.000352	0.00249	CcSEcCtD
Mitotane—Visual impairment—Betamethasone—psoriatic arthritis	0.000345	0.00244	CcSEcCtD
Mitotane—Visual impairment—Dexamethasone—psoriatic arthritis	0.000345	0.00244	CcSEcCtD
Mitotane—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000345	0.00244	CcSEcCtD
Mitotane—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000343	0.00242	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—psoriatic arthritis	0.000341	0.00241	CcSEcCtD
Mitotane—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000337	0.00238	CcSEcCtD
Mitotane—Vertigo—Prednisolone—psoriatic arthritis	0.000336	0.00237	CcSEcCtD
Mitotane—Eye disorder—Dexamethasone—psoriatic arthritis	0.000335	0.00237	CcSEcCtD
Mitotane—Eye disorder—Betamethasone—psoriatic arthritis	0.000335	0.00237	CcSEcCtD
Mitotane—Angiopathy—Betamethasone—psoriatic arthritis	0.000325	0.0023	CcSEcCtD
Mitotane—Angiopathy—Dexamethasone—psoriatic arthritis	0.000325	0.0023	CcSEcCtD
Mitotane—Hypertension—Prednisolone—psoriatic arthritis	0.000323	0.00228	CcSEcCtD
Mitotane—Vertigo—Triamcinolone—psoriatic arthritis	0.000309	0.00218	CcSEcCtD
Mitotane—Vertigo—Methylprednisolone—psoriatic arthritis	0.000308	0.00218	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000307	0.00217	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—psoriatic arthritis	0.000305	0.00215	CcSEcCtD
Mitotane—Shock—Prednisolone—psoriatic arthritis	0.0003	0.00212	CcSEcCtD
Mitotane—Hypertension—Triamcinolone—psoriatic arthritis	0.000297	0.0021	CcSEcCtD
Mitotane—Hypertension—Methylprednisolone—psoriatic arthritis	0.000296	0.00209	CcSEcCtD
Mitotane—Eye disorder—Prednisone—psoriatic arthritis	0.000292	0.00206	CcSEcCtD
Mitotane—Infestation—Methotrexate—psoriatic arthritis	0.000291	0.00205	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—psoriatic arthritis	0.000291	0.00205	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—psoriatic arthritis	0.000291	0.00205	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00029	0.00205	CcSEcCtD
Mitotane—Flushing—Prednisone—psoriatic arthritis	0.00029	0.00205	CcSEcCtD
Mitotane—Angiopathy—Prednisone—psoriatic arthritis	0.000283	0.002	CcSEcCtD
Mitotane—Confusional state—Methylprednisolone—psoriatic arthritis	0.000282	0.00199	CcSEcCtD
Mitotane—Vertigo—Dexamethasone—psoriatic arthritis	0.00028	0.00198	CcSEcCtD
Mitotane—Vertigo—Betamethasone—psoriatic arthritis	0.00028	0.00198	CcSEcCtD
Mitotane—Infection—Triamcinolone—psoriatic arthritis	0.000279	0.00197	CcSEcCtD
Mitotane—Infection—Methylprednisolone—psoriatic arthritis	0.000278	0.00197	CcSEcCtD
Mitotane—Haematuria—Methotrexate—psoriatic arthritis	0.000277	0.00196	CcSEcCtD
Mitotane—Shock—Triamcinolone—psoriatic arthritis	0.000276	0.00195	CcSEcCtD
Mitotane—Shock—Methylprednisolone—psoriatic arthritis	0.000276	0.00195	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000275	0.00194	CcSEcCtD
Mitotane—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000275	0.00194	CcSEcCtD
Mitotane—Paraesthesia—Prednisolone—psoriatic arthritis	0.000274	0.00194	CcSEcCtD
Mitotane—Mental disorder—Prednisone—psoriatic arthritis	0.000274	0.00193	CcSEcCtD
Mitotane—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000272	0.00192	CcSEcCtD
Mitotane—Malnutrition—Prednisone—psoriatic arthritis	0.000272	0.00192	CcSEcCtD
Mitotane—Hypertension—Dexamethasone—psoriatic arthritis	0.000269	0.0019	CcSEcCtD
Mitotane—Hypertension—Betamethasone—psoriatic arthritis	0.000269	0.0019	CcSEcCtD
Mitotane—Hypotension—Methylprednisolone—psoriatic arthritis	0.000262	0.00185	CcSEcCtD
Mitotane—Pain—Prednisolone—psoriatic arthritis	0.000261	0.00184	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—psoriatic arthritis	0.000261	0.00184	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000258	0.00182	CcSEcCtD
Mitotane—Vision blurred—Prednisone—psoriatic arthritis	0.000256	0.00181	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—psoriatic arthritis	0.000256	0.00181	CcSEcCtD
Mitotane—Infection—Betamethasone—psoriatic arthritis	0.000253	0.00179	CcSEcCtD
Mitotane—Infection—Dexamethasone—psoriatic arthritis	0.000253	0.00179	CcSEcCtD
Mitotane—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000252	0.00178	CcSEcCtD
Mitotane—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000252	0.00178	CcSEcCtD
Mitotane—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000251	0.00178	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—psoriatic arthritis	0.000251	0.00178	CcSEcCtD
Mitotane—Anaemia—Prednisone—psoriatic arthritis	0.000251	0.00177	CcSEcCtD
Mitotane—Shock—Betamethasone—psoriatic arthritis	0.000251	0.00177	CcSEcCtD
Mitotane—Shock—Dexamethasone—psoriatic arthritis	0.000251	0.00177	CcSEcCtD
Mitotane—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00025	0.00176	CcSEcCtD
Mitotane—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00025	0.00176	CcSEcCtD
Mitotane—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000249	0.00176	CcSEcCtD
Mitotane—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000249	0.00176	CcSEcCtD
Mitotane—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000247	0.00175	CcSEcCtD
Mitotane—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000247	0.00174	CcSEcCtD
Mitotane—Vertigo—Prednisone—psoriatic arthritis	0.000244	0.00172	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—psoriatic arthritis	0.000244	0.00172	CcSEcCtD
Mitotane—Anorexia—Betamethasone—psoriatic arthritis	0.000243	0.00171	CcSEcCtD
Mitotane—Anorexia—Dexamethasone—psoriatic arthritis	0.000243	0.00171	CcSEcCtD
Mitotane—Pain—Triamcinolone—psoriatic arthritis	0.00024	0.0017	CcSEcCtD
Mitotane—Hypotension—Betamethasone—psoriatic arthritis	0.000238	0.00168	CcSEcCtD
Mitotane—Hypotension—Dexamethasone—psoriatic arthritis	0.000238	0.00168	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—psoriatic arthritis	0.000237	0.00167	CcSEcCtD
Mitotane—Hypertension—Prednisone—psoriatic arthritis	0.000235	0.00166	CcSEcCtD
Mitotane—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000231	0.00163	CcSEcCtD
Mitotane—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000231	0.00163	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00023	0.00162	CcSEcCtD
Mitotane—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000229	0.00162	CcSEcCtD
Mitotane—Paraesthesia—Betamethasone—psoriatic arthritis	0.000229	0.00162	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—psoriatic arthritis	0.000229	0.00161	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—psoriatic arthritis	0.000227	0.0016	CcSEcCtD
Mitotane—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000225	0.00159	CcSEcCtD
Mitotane—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000224	0.00158	CcSEcCtD
Mitotane—Dyspepsia—Betamethasone—psoriatic arthritis	0.000224	0.00158	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—psoriatic arthritis	0.000222	0.00157	CcSEcCtD
Mitotane—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000222	0.00157	CcSEcCtD
Mitotane—Decreased appetite—Betamethasone—psoriatic arthritis	0.000221	0.00156	CcSEcCtD
Mitotane—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000221	0.00156	CcSEcCtD
Mitotane—Infection—Prednisone—psoriatic arthritis	0.00022	0.00156	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00022	0.00155	CcSEcCtD
Mitotane—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00022	0.00155	CcSEcCtD
Mitotane—Shock—Prednisone—psoriatic arthritis	0.000218	0.00154	CcSEcCtD
Mitotane—Pain—Dexamethasone—psoriatic arthritis	0.000218	0.00154	CcSEcCtD
Mitotane—Pain—Betamethasone—psoriatic arthritis	0.000218	0.00154	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—psoriatic arthritis	0.000218	0.00154	CcSEcCtD
Mitotane—Skin disorder—Prednisone—psoriatic arthritis	0.000215	0.00152	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—psoriatic arthritis	0.000214	0.00151	CcSEcCtD
Mitotane—Anorexia—Prednisone—psoriatic arthritis	0.000211	0.00149	CcSEcCtD
Mitotane—Anaemia—Methotrexate—psoriatic arthritis	0.00021	0.00148	CcSEcCtD
Mitotane—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00021	0.00148	CcSEcCtD
Mitotane—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00021	0.00148	CcSEcCtD
Mitotane—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000207	0.00146	CcSEcCtD
Mitotane—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000206	0.00146	CcSEcCtD
Mitotane—Vertigo—Methotrexate—psoriatic arthritis	0.000204	0.00144	CcSEcCtD
Mitotane—Dizziness—Prednisolone—psoriatic arthritis	0.000202	0.00143	CcSEcCtD
Mitotane—Asthenia—Triamcinolone—psoriatic arthritis	0.000201	0.00142	CcSEcCtD
Mitotane—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000201	0.00142	CcSEcCtD
Mitotane—Body temperature increased—Betamethasone—psoriatic arthritis	0.000201	0.00142	CcSEcCtD
Mitotane—Asthenia—Methylprednisolone—psoriatic arthritis	0.000201	0.00142	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—psoriatic arthritis	0.000199	0.00141	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—psoriatic arthritis	0.000195	0.00138	CcSEcCtD
Mitotane—Decreased appetite—Prednisone—psoriatic arthritis	0.000193	0.00136	CcSEcCtD
Mitotane—Rash—Prednisolone—psoriatic arthritis	0.000192	0.00136	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—psoriatic arthritis	0.000192	0.00136	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000192	0.00136	CcSEcCtD
Mitotane—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000192	0.00135	CcSEcCtD
Mitotane—Headache—Prednisolone—psoriatic arthritis	0.000191	0.00135	CcSEcCtD
Mitotane—Confusional state—Methotrexate—psoriatic arthritis	0.000187	0.00132	CcSEcCtD
Mitotane—Dizziness—Triamcinolone—psoriatic arthritis	0.000186	0.00131	CcSEcCtD
Mitotane—Dizziness—Methylprednisolone—psoriatic arthritis	0.000185	0.00131	CcSEcCtD
Mitotane—Infection—Methotrexate—psoriatic arthritis	0.000184	0.0013	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—psoriatic arthritis	0.000183	0.00129	CcSEcCtD
Mitotane—Asthenia—Dexamethasone—psoriatic arthritis	0.000183	0.00129	CcSEcCtD
Mitotane—Asthenia—Betamethasone—psoriatic arthritis	0.000183	0.00129	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000182	0.00128	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000181	0.00128	CcSEcCtD
Mitotane—Nausea—Prednisolone—psoriatic arthritis	0.000181	0.00128	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—psoriatic arthritis	0.00018	0.00127	CcSEcCtD
Mitotane—Vomiting—Triamcinolone—psoriatic arthritis	0.000178	0.00126	CcSEcCtD
Mitotane—Vomiting—Methylprednisolone—psoriatic arthritis	0.000178	0.00126	CcSEcCtD
Mitotane—Rash—Triamcinolone—psoriatic arthritis	0.000177	0.00125	CcSEcCtD
Mitotane—Dermatitis—Triamcinolone—psoriatic arthritis	0.000177	0.00125	CcSEcCtD
Mitotane—Anorexia—Methotrexate—psoriatic arthritis	0.000177	0.00125	CcSEcCtD
Mitotane—Rash—Methylprednisolone—psoriatic arthritis	0.000177	0.00125	CcSEcCtD
Mitotane—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000176	0.00125	CcSEcCtD
Mitotane—Headache—Triamcinolone—psoriatic arthritis	0.000176	0.00124	CcSEcCtD
Mitotane—Headache—Methylprednisolone—psoriatic arthritis	0.000175	0.00124	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—psoriatic arthritis	0.000175	0.00124	CcSEcCtD
Mitotane—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000174	0.00123	CcSEcCtD
Mitotane—Diarrhoea—Betamethasone—psoriatic arthritis	0.000174	0.00123	CcSEcCtD
Mitotane—Hypotension—Methotrexate—psoriatic arthritis	0.000173	0.00122	CcSEcCtD
Mitotane—Dizziness—Dexamethasone—psoriatic arthritis	0.000168	0.00119	CcSEcCtD
Mitotane—Dizziness—Betamethasone—psoriatic arthritis	0.000168	0.00119	CcSEcCtD
Mitotane—Nausea—Triamcinolone—psoriatic arthritis	0.000167	0.00118	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—psoriatic arthritis	0.000166	0.00118	CcSEcCtD
Mitotane—Nausea—Methylprednisolone—psoriatic arthritis	0.000166	0.00118	CcSEcCtD
Mitotane—Somnolence—Methotrexate—psoriatic arthritis	0.000165	0.00116	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—psoriatic arthritis	0.000163	0.00115	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—psoriatic arthritis	0.000163	0.00115	CcSEcCtD
Mitotane—Vomiting—Betamethasone—psoriatic arthritis	0.000162	0.00114	CcSEcCtD
Mitotane—Vomiting—Dexamethasone—psoriatic arthritis	0.000162	0.00114	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—psoriatic arthritis	0.000161	0.00114	CcSEcCtD
Mitotane—Rash—Dexamethasone—psoriatic arthritis	0.000161	0.00113	CcSEcCtD
Mitotane—Rash—Betamethasone—psoriatic arthritis	0.000161	0.00113	CcSEcCtD
Mitotane—Dermatitis—Betamethasone—psoriatic arthritis	0.00016	0.00113	CcSEcCtD
Mitotane—Dermatitis—Dexamethasone—psoriatic arthritis	0.00016	0.00113	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00016	0.00113	CcSEcCtD
Mitotane—Headache—Betamethasone—psoriatic arthritis	0.00016	0.00113	CcSEcCtD
Mitotane—Headache—Dexamethasone—psoriatic arthritis	0.00016	0.00113	CcSEcCtD
Mitotane—Asthenia—Prednisone—psoriatic arthritis	0.000159	0.00112	CcSEcCtD
Mitotane—Pain—Methotrexate—psoriatic arthritis	0.000159	0.00112	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000153	0.00108	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—psoriatic arthritis	0.000152	0.00107	CcSEcCtD
Mitotane—Nausea—Betamethasone—psoriatic arthritis	0.000151	0.00107	CcSEcCtD
Mitotane—Nausea—Dexamethasone—psoriatic arthritis	0.000151	0.00107	CcSEcCtD
Mitotane—Dizziness—Prednisone—psoriatic arthritis	0.000147	0.00104	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—psoriatic arthritis	0.000147	0.00104	CcSEcCtD
Mitotane—Vomiting—Prednisone—psoriatic arthritis	0.000141	0.000996	CcSEcCtD
Mitotane—Rash—Prednisone—psoriatic arthritis	0.00014	0.000988	CcSEcCtD
Mitotane—Dermatitis—Prednisone—psoriatic arthritis	0.00014	0.000987	CcSEcCtD
Mitotane—Headache—Prednisone—psoriatic arthritis	0.000139	0.000982	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000137	0.000965	CcSEcCtD
Mitotane—Asthenia—Methotrexate—psoriatic arthritis	0.000133	0.000939	CcSEcCtD
Mitotane—Nausea—Prednisone—psoriatic arthritis	0.000132	0.000931	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—psoriatic arthritis	0.000127	0.000896	CcSEcCtD
Mitotane—Dizziness—Methotrexate—psoriatic arthritis	0.000123	0.000866	CcSEcCtD
Mitotane—Vomiting—Methotrexate—psoriatic arthritis	0.000118	0.000833	CcSEcCtD
Mitotane—Rash—Methotrexate—psoriatic arthritis	0.000117	0.000826	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—psoriatic arthritis	0.000117	0.000825	CcSEcCtD
Mitotane—Headache—Methotrexate—psoriatic arthritis	0.000116	0.00082	CcSEcCtD
Mitotane—Nausea—Methotrexate—psoriatic arthritis	0.00011	0.000778	CcSEcCtD
